Press Releases

Mithra Successfully Raises EUR 65 Million By Means of a Private Placement via an Accelerated Bookbuild Offering
18 June 2020
EN FR

Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy
18 June 2020
EN FR

Mithra Signs LSA for Commercialization of Tibelia® in Liechtenstein and Switzerland
11 June 2020
EN FR

Mithra Issues First Put Option Notice Under Capital Agreement with LDA Capital
5 June 2020
EN FR

Mithra Signs License and Supply Agreement with Mayne Pharma for Commercialization of Estelle in Australia
28 May 2020
EN FR

Mithra Launches a Research Programme on Estetrol’s Effect in Covid-19 Treatment
25 May 2020
EN FR

Mithra and Searchlight Pharma Announce Filing of New Drug Submission for Estelle® in Canada
20 May 2020
EN FR

Mithra and Gynial Sign Commercialization Agreement for Myring™ in Switzerland
5 May 2020
EN FR

Mithra Obtains a Capital Commitment Agreement of EUR 50 Million from Partner LDA Capital
24 April 2020
EN FR

Mithra Releases 2019 Annual Report and Invitation to its Securities holders’ Meeting
22 April 2020
EN FR

Mayne Pharma Submits New Drug Application For E4/DRSP to the FDA
16 April 2020
EN FR

Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe
2 April 2020
EN FR